Challenges of Genomic Testing for Hereditary Breast and Ovarian Cancers
Open Access
- 1 January 2021
- journal article
- review article
- Published by Taylor & Francis Ltd in The Application of Clinical Genetics
- Vol. ume 14, 1-9
- https://doi.org/10.2147/tacg.s245021
Abstract
Completion of genetic testing is increasingly important for the complex care of patients with suspected hereditary breast and ovarian cancers (HBOC) and their at-risk family members. Identification of individuals with pathogenic variants has implications for targeted treatment recommendations, risk reduction strategies, increased surveillance recommendations, as well as the genetic testing of family members, known as cascade testing or screening. Due to advances in technology and decreasing costs, what was once single-gene genetic testing has evolved into large-scale multi-gene panel genomic testing. As germline genomic testing for HBOC becomes more and more available, it is important to identify the challenges that are associated with its use. In this manuscript, we review the current issues faced by germline genomic testing for HBOC which include effectively managing the marked increases in genetic referrals, interpreting the vast amount of information yielded by newer testing methods such as next generation sequencing (NGS), recognizing the need for better cascade screening strategies, potential exacerbation of health disparities and improving support for patients navigating the emotional impact related to positive, negative and indeterminate testing results.Keywords
This publication has 64 references indexed in Scilit:
- The Need to Build Trust: A Perspective on Disparities in Genetic TestingGenetic Testing and Molecular Biomarkers, 2013
- Telegenetics: a systematic review of telemedicine in genetics servicesGenetics in Medicine, 2012
- ‘Cancer doesn’t have an age’: Genetic testing and cancer risk management in BRCA1/2 mutation-positive women aged 18–24Health: An Interdisciplinary Journal for the Social Study of Health, Illness and Medicine, 2012
- Long-Term Psychosocial Outcomes of BRCA1/BRCA2 Testing: Differences across Affected Status and Risk-Reducing Surgery ChoiceCancer Epidemiology, Biomarkers & Prevention, 2012
- Mutations in 12 genes for inherited ovarian, fallopian tube, and peritoneal carcinoma identified by massively parallel sequencingProceedings of the National Academy of Sciences of the United States of America, 2011
- The prevalence of BRCA1 mutations among young women with triple-negative breast cancerBMC Cancer, 2009
- Family letters are an effective way to inform relatives about inherited cardiac diseaseAmerican Journal of Medical Genetics Part A, 2009
- Next-generation DNA sequencingNature Biotechnology, 2008
- Meta-Analysis of BRCA1 and BRCA2 PenetranceJournal of Clinical Oncology, 2007
- The impact of proband mediated information dissemination in families with a BRCA1/2 gene mutationJournal of Medical Genetics, 2004